MediWound Ltd. - Ordinary Shares — Financial Statements (NASDAQ:MDWD) | MetaTrader

Open full chart

News

Guardian Pharmacy (GRDN) Surges 8.8%: Is This an Indication of Further Gains?

MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates

NRx Pharmaceuticals, Inc. (NRXP) Reports Q1 Loss, Lags Revenue Estimates

Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Misses Revenue Estimates

Journey Medical Corporation (DERM) Reports Q1 Loss, Beats Revenue Estimates

Profound Medical (PROF) Reports Q1 Loss, Tops Revenue Estimates

MediWound (MDWD) Reports Q4 Loss, Lags Revenue Estimates

Mediwound earnings beat by $0.03, revenue fell short of estimates

MediWound at Oppenheimer Conference: Strategic Growth and Innovation

MediWound schedules extraordinary general meeting for February 19

MediWound reports NexoBrid reduces traumatic tattoos by over 90%

MediWound stock price target raised to $36 from $31 at H.C. Wainwright